Compare Gitlab Inc (GTLB) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gitlab Inc vs Altria Group Inc — how do they compare? Gitlab Inc trades at $53.51 (market cap $8.66B), while Altria Group Inc trades at $71.29 (market cap $115.85B). The key difference: Altria Group Inc is far larger — about 13.4× Gitlab Inc's market cap, and Altria Group Inc pays a 6.4% dividend while Gitlab Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gitlab Inc for 62 Days and Altria Group Inc for 154 Days on average.
| GTLB | MO | |
|---|---|---|
Market Cap | $8.66B | $115.85B |
Volume | 2,403,535 | 6,934,962 |
Sector | Technology | Consumer Staples |
52-Week High | $53.56 | $74.92 |
52-Week Low | $19.42 | $54.72 |
Typical Hold Time | 62 Days | 154 Days |
Enterprise Value | $7.40B | $138.06B |
Dividend Yield | — | 6.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GitLab (GTLB) trades at $53.56, up 3.74% today and near its 52-week high, with strong technical momentum. The company shows accelerating revenue growth (21.3% YoY in Q2 2026) and consistent earnings beats, though profitability remains negative. Recent AI product traction and raised guidance have fueled investor optimism, with the stock gaining 35% in August 2026 alone.
Outlook is mixed: strong sales momentum and AI integration offer upside, but high valuation (P/E 521) and negative margins pose risks. Analyst consensus is cautious (36.7% Buy, 60% Hold) with a $49.71 price target below current levels, suggesting limited near-term upside despite positive business trends.
Altria Group (MO) trades at $71.43, up 4.2% today, showing strong momentum despite mixed earnings history with two misses and one beat in recent quarters. The stock maintains a 6.6% dividend yield with 60 consecutive annual increases, supported by robust cash flow generation. Technical indicators show a bullish trend with current price near resistance at $71, while fundamentals reveal stable revenue around $20B annually but declining profit margins from 55.1% in 2024 to 34.5% in 2025.
MO presents a high-yield opportunity with strong cash flows but faces significant headwinds including negative shareholder equity, regulatory pressures, and declining cigarette volumes. Analyst consensus remains positive with 62% buy ratings and $69.71 price target, though the stock trades slightly above this target. The company's transition to smoke-free products remains critical for long-term sustainability amid changing consumer preferences.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gitlab Inc
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
